MedPath

Prevention of Post-partum Haemorrhage

Not Applicable
Completed
Conditions
Postpartum Haemorrhage
Immediate Postpartum Hemorrhage
Interventions
Procedure: controlled cord traction
Procedure: Clinical signs of placental separation
Registration Number
NCT01044082
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

The primary purpose of the trial is to evaluate whether the management of placental delivery with controlled cord traction (CCT) reduces the incidence of postpartum haemorrhage, compared with management waiting for clinical signs of spontaneous placental separation, in women with vaginal delivery receiving prophylactic oxytocin for the management of the third stage of labour.

The hypothesis is that CCT, by reducing the length of the third stage of labour, facilitates early postpartum uterine contraction and local haemostasis and decreases post partum blood loss.

Detailed Description

In this randomized controlled trial, conducted in 6 maternity units, information will be provided to eligible women during a prenatal visit in late pregnancy. Once in labour ward, during labour and before delivery, and if eligible and willing to participate, the woman will be randomly allocated to the intervention or reference group.

In all women, immediately after the birth of the baby, 5 IU prophylactic oxytocin will be intravenously administered, the umbilical cord will be early clamped and cut, and a collector bag placed under the woman's buttocks.

In the intervention group, controlled cord traction will be applied as soon as a firm uterine contraction is obtained, and until placental delivery occurs.

In the reference group, clinical signs of placental separation will be awaited for, and then placental expulsion may be helped through maternal pushing and/or hypogastric pressure.

All other aspects of the management of the third stage will be standardized and common to all women.

On day 2 postpartum, a venous blood sample will be collected to measure plasma haemoglobin and haematocrit. On the same day, a questionnaire will be filled in by the woman to assess her satisfaction.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
4382
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
controlled cord tractioncontrolled cord tractionControlled cord traction will be applied as soon as a firm uterine contraction is obtained, and until placental delivery occurs.
clinical signs of placental separationClinical signs of placental separationClinical signs of placental separation will be awaited for, and then placental expulsion may be helped through maternal pushing and/or hypogastric pressure
Primary Outcome Measures
NameTimeMethod
Incidence of postpartum haemorrhage, defined as a measured postpartum blood loss greater than 500 mLimmediately to two hours after delivery
Secondary Outcome Measures
NameTimeMethod
Postpartum transfusionTime after delivery
Severe postpartum haemorrhage, defined as a measured postpartum blood loss greater than 1000mLimmediately to two hours after delivery
Measured postpartum blood loss at 30 minutes after deliveryat 30 minutes after delivery
Total measured postpartum blood lossTime after delivery
Curative postpartum uterotonic treatmentTime after delivery
Postpartum embolization or surgery for haemorrhageTime after delivery
Peripartum haemoglobin deltaTime after delivery
Peripartum haematocrit deltaTime after delivery
Duration of third stage of labourtime before delivery
Deliveries with manual removal of placenta30 minutes
Potential adverse events: uterine inversion, cord rupture, pain during third stage of labourTime after delivery
Woman's satisfactiontwo days after delivery

Trial Locations

Locations (1)

Maternité de Port-Royal

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath